The average one-year price target for Molecular Partners (OTCPK:MLLCF) has been revised to $13.25 / share. This is an increase of 85.65% from the prior estimate of $7.14 dated June 11, 2024.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $7.50 to a high of $19.48 / share. The average price target represents an increase of 244.14% from the latest reported closing price of $3.85 / share.
What is the Fund Sentiment?
There are 5 funds or institutions reporting positions in Molecular Partners. This is an increase of 1 owner(s) or 25.00% in the last quarter. Average portfolio weight of all funds dedicated to MLLCF is 0.00%, an increase of 10.83%. Total shares owned by institutions increased in the last three months by 104.16% to 21K shares.
What are Other Shareholders Doing?
Old Mission Capital holds 11K shares representing 0.03% ownership of the company.
DFA INVESTMENT DIMENSIONS GROUP INC - International Vector Equity Portfolio Shares holds 5K shares representing 0.01% ownership of the company. No change in the last quarter.
DFA INVESTMENT DIMENSIONS GROUP INC - World ex U.S. Core Equity Portfolio Institutional Class Shares holds 4K shares representing 0.01% ownership of the company. No change in the last quarter.
SPEU - SPDR(R) Portfolio Europe ETF holds 1K shares representing 0.00% ownership of the company. In its prior filing, the firm reported owning 2K shares , representing a decrease of 69.23%. The firm decreased its portfolio allocation in MLLCF by 12.30% over the last quarter.
AVDE - Avantis International Equity ETF holds 0K shares representing 0.00% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
